CINECA IRIS Institutional Research Information System

CAMODECA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.389
EU - Europa 618
AS - Asia 238
AF - Africa 30
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.370
IT - Italia 292
SE - Svezia 105
CN - Cina 104
SG - Singapore 69
BG - Bulgaria 59
DE - Germania 50
FR - Francia 41
VN - Vietnam 33
GB - Regno Unito 32
CA - Canada 19
SN - Senegal 13
NG - Nigeria 11
RU - Federazione Russa 10
FI - Finlandia 9
IN - India 9
HK - Hong Kong 7
BE - Belgio 4
CI - Costa d'Avorio 4
JP - Giappone 4
TR - Turchia 4
TW - Taiwan 4
UA - Ucraina 4
BR - Brasile 3
ES - Italia 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
IL - Israele 2
MA - Marocco 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
HU - Ungheria 1
PL - Polonia 1
SI - Slovenia 1
VE - Venezuela 1
Totale 2.284
Salva come PNG Salva come JPEG
Città #
Fairfield 192
Woodbridge 129
Chandler 114
Seattle 113
Houston 101
Ashburn 99
Serra 90
Ann Arbor 81
Cambridge 76
Wilmington 67
Sofia 59
Beijing 49
New York 48
Princeton 36
Singapore 34
Boardman 30
Florence 27
London 27
Lawrence 23
Medford 22
Bremen 20
Des Moines 20
Marseille 20
Pisa 19
Ottawa 18
Trieste 17
Boulder 16
Dong Ket 15
Dakar 13
Lagos 11
Dallas 10
Bergamo 9
Frankfurt am Main 9
Pessac 9
Santa Clara 9
Milan 8
Nanjing 8
Ogden 8
Hebei 6
Hong Kong 6
Livorno 6
San Diego 6
Viareggio 6
Rome 5
Abidjan 4
Brussels 4
Cadoneghe 4
Jiaxing 4
Kaohsiung 4
Talence 4
Dearborn 3
Hefei 3
Kunming 3
Los Angeles 3
Munich 3
Norwalk 3
Phoenix 3
Pistoia 3
Ponte Buggianese 3
Washington 3
Amsterdam 2
Canberra 2
Cesano Maderno 2
Gallarate 2
Genoa 2
Grafing 2
Hangzhou 2
Jinan 2
Madrid 2
Mumbai 2
Nanchang 2
Pomezia 2
Shanghai 2
Shenyang 2
Tianjin 2
Vienna 2
Yenibosna 2
Azor 1
Bangalore 1
Bari 1
Berlin 1
Bern 1
Bogotá 1
Bridge 1
Brindisi 1
Budapest 1
Bures-sur-Yvette 1
Capannori 1
Caracas 1
Central 1
Chehalis 1
Chengdu 1
Chiusi 1
Clifton 1
Cormons 1
Dhaka 1
Donetsk 1
Dubai 1
Düsseldorf 1
Edinburgh 1
Totale 1.802
Salva come PNG Salva come JPEG
Nome #
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 165
ADAM metalloproteinases as potential drug targets 143
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 131
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies 121
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors 116
Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration 111
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models 107
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 107
MMP-8 Is Critical for Dexamethasone Therapy in Alkali-Burned Corneas Under Dry Eye Conditions 107
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 106
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 103
Synthesis, experimental evaluation and molecular modelling of hydroxamate derivatives as zinc metalloproteinase inhibitors 102
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 100
Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles 94
Mimicking the intramolecular hydrogen bond: Synthesis, biological evaluation, andmolecular modeling of benzoxazines and quinazolines as potential antimalarial agents 87
Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes 86
Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: Further structure-activity relationships, in vivo studies, and preliminary toxicity profiling 77
Inhibitors of A Disintegrin And Metalloproteinases-10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect 73
Monoaryl derivatives as transthyretin fibril formation inhibitors: Design, synthesis, biological evaluation and structural analysis 72
null 69
null 58
Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms 57
Multifunctional Small Molecules as Potential Anti-Alzheimer's Disease Agents 49
null 45
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing 30
Resveratrol-like Compounds as SIRT1 Activators 27
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors 19
From Waste Vegetable Oil to a Green Compatibilizer for HDPE/PA6 Blends 19
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease 18
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors 16
Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells 15
Totale 2.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020381 0 0 0 40 44 52 43 42 43 47 53 17
2020/2021319 10 24 5 4 15 43 30 15 44 50 21 58
2021/2022326 16 20 6 10 54 47 20 16 11 19 15 92
2022/2023456 44 72 45 30 44 56 10 29 76 0 32 18
2023/2024251 14 14 15 13 43 49 26 9 2 5 33 28
2024/202596 7 31 52 6 0 0 0 0 0 0 0 0
Totale 2.430